Cargando…
Preclinical Bioavailability, Tissue Distribution, and Protein Binding Studies of Erinacine A, a Bioactive Compound from Hericium erinaceus Mycelia Using Validated LC-MS/MS Method
Erinacine A, derived from the mycelia of Hericium erinaceus, has attracted much attention due to its neuroprotective properties. However, very few studies have been conducted on the bioavailability, tissue distribution, and protein binding of erinacine A. This study aimed to investigate the bioavail...
Autores principales: | Tsai, Pei-Ching, Wu, Yi-Kai, Hu, Jun-Hao, Li, I-Chen, Lin, Ting-Wei, Chen, Chin-Chu, Kuo, Chia-Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347307/ https://www.ncbi.nlm.nih.gov/pubmed/34361662 http://dx.doi.org/10.3390/molecules26154510 |
Ejemplares similares
-
Absolute Bioavailability, Tissue Distribution, and Excretion of Erinacine S in Hericium erinaceus Mycelia
por: Hu, Jun-Hao, et al.
Publicado: (2019) -
Neurohealth Properties of Hericium erinaceus Mycelia Enriched with Erinacines
por: Li, I-Chen, et al.
Publicado: (2018) -
Erinacine A-enriched Hericium erinaceus mycelia promotes longevity in Drosophila melanogaster and aged mice
por: Li, I-Chen, et al.
Publicado: (2019) -
Genotoxicity profile of erinacine A-enriched Hericium erinaceus mycelium
por: Li, I-Chen, et al.
Publicado: (2014) -
Prevention of Early Alzheimer’s Disease by Erinacine A-Enriched Hericium erinaceus Mycelia Pilot Double-Blind Placebo-Controlled Study
por: Li, I-Chen, et al.
Publicado: (2020)